Cargando…

Immunotherapy Enhancement by Targeting Extracellular Tumor pH in Triple-Negative Breast Cancer Mouse Model

SIMPLE SUMMARY: Despite remarkable progress in immunotherapy, most advanced cancer patients still show intrinsic or naturally acquired resistance to immune checkpoint blockade strategies leading to treatment failure. Breast cancer produces lactate and protons in tumor cells, which are secreted to ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahman, Azizur, Janic, Branislava, Rahman, Tasnim, Singh, Harshit, Ali, Haythem, Rattan, Ramandeep, Kazi, Mohsin, Ali, Meser M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605606/ https://www.ncbi.nlm.nih.gov/pubmed/37894298 http://dx.doi.org/10.3390/cancers15204931

Ejemplares similares

MRI to assess chemoprevention in transgenic adenocarcinoma of mouse prostate (TRAMP)
por: Arbab, Ali S, et al.
Publicado: (2011)

Differential biodistribution of intravenously administered endothelial progenitor and cytotoxic T-cells in rat bearing orthotopic human glioma
por: Varma, Nadimpalli Ravi S, et al.
Publicado: (2013)

Changes in Vascular Permeability and Expression of Different Angiogenic Factors Following Anti-Angiogenic Treatment in Rat Glioma
por: Ali, Meser M., et al.
Publicado: (2010)

Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH
por: Rao, Jyotsna U., et al.
Publicado: (2017)

MRI Tracking of FePro Labeled Fresh and Cryopreserved Long Term In Vitro Expanded Human Cord Blood AC133+ Endothelial Progenitor Cells in Rat Glioma
por: Janic, Branislava, et al.
Publicado: (2012)

The Role and Therapeutic Potential of Endothelial Progenitor Cells in Tumor Neovascularization
por: Janic, Branislava, et al.
Publicado: (2010)

Therapeutic enhancement of radiation and immunomodulation by gold nanoparticles in triple negative breast cancer
por: Janic, Branislava, et al.
Publicado: (2021)

pH-Responsive Liposomes of Dioleoyl Phosphatidylethanolamine and Cholesteryl Hemisuccinate for the Enhanced Anticancer Efficacy of Cisplatin
por: Shah, Hassan, et al.
Publicado: (2022)

Collagen of Extracellular Matrix from Marine Invertebrates and Its Medical Applications
por: Rahman, M. Azizur
Publicado: (2019)

Endothelial Progenitor Cells (EPCs) as Gene Carrier System for Rat Model of Human Glioma
por: Varma, Nadimpalli Ravi S., et al.
Publicado: (2012)

Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021)

Subcurative radiation significantly increases cell proliferation, invasion, and migration of primary glioblastoma multiforme in vivo
por: Shankar, Adarsh, et al.
Publicado: (2014)

Roles of long noncoding RNA in triple‐negative breast cancer
por: Das, Plabon Kumar, et al.
Publicado: (2023)

Development of Curcumin and Piperine-Loaded Bio-Active Self-Nanoemulsifying Drugs and Investigation of Their Bioactivity in Zebrafish Embryos and Human Hematological Cancer Cell Lines
por: Kazi, Mohsin, et al.
Publicado: (2023)

HDAC inhibition potentiates immunotherapy in triple negative breast cancer
por: Terranova-Barberio, Manuela, et al.
Publicado: (2017)

Immunotherapy Treatment for Triple Negative Breast Cancer
por: Berger, Elizabeth R., et al.
Publicado: (2021)

Prospects of Immunotherapy for Triple-Negative Breast Cancer
por: Qiu, Dan, et al.
Publicado: (2022)

Immunotherapy for the Treatment of Triple-Negative Breast Cancer
por: Tolaney, Sara M., et al.
Publicado: (2022)

Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Spatial predictors of immunotherapy response in triple-negative breast cancer
por: Wang, Xiao Qian, et al.
Publicado: (2023)

Regression and Eradication of Triple-Negative Breast Carcinoma in 4T1 Mouse Model by Combination Immunotherapies
por: Nahar, Saifun, et al.
Publicado: (2023)

Terahertz Reflectometry Imaging of Carbon Nanomaterials for Biological Application
por: Ghann, William, et al.
Publicado: (2019)

The clinical promise of immunotherapy in triple-negative breast cancer
por: Vikas, Praveen, et al.
Publicado: (2018)

Modern Immunotherapy in the Treatment of Triple-Negative Breast Cancer
por: Wesolowski, Jakub, et al.
Publicado: (2022)

Clinical trials of immunotherapy in triple-negative breast cancer
por: Howard, Frederick M., et al.
Publicado: (2022)

Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer
por: Luo, Chenyi, et al.
Publicado: (2022)

Correction: Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Effects of Ferumoxides – Protamine Sulfate Labeling on Immunomodulatory Characteristics of Macrophage-like THP-1 Cells
por: Janic, Branislava, et al.
Publicado: (2008)

Feline immunodeficiency virus-mediated long-term transgene expression in undifferentiated retinal progenitor cells and its downregulation in differentiated cells
por: Janic, Branislava, et al.
Publicado: (2008)

Applications of Extracellular Vesicles in Triple-Negative Breast Cancer
por: St-Denis-Bissonnette, Frederic, et al.
Publicado: (2022)

Recent advances in triple negative breast cancer: the immunotherapy era
por: Marra, Antonio, et al.
Publicado: (2019)

Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
por: Mediratta, Karan, et al.
Publicado: (2020)

Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer
por: Llinàs-Arias, Pere, et al.
Publicado: (2021)

Research progress on immunotherapy in triple-negative breast cancer (Review)
por: Zhang, Xiaoxiao, et al.
Publicado: (2022)

Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitors
por: Abdou, Yara, et al.
Publicado: (2022)

Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
por: Loizides, Sotiris, et al.
Publicado: (2023)

Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer
por: Jacobs, Flavia, et al.
Publicado: (2023)

Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer
por: Zheng, Yiwen, et al.
Publicado: (2023)

Neoadjuvant immunotherapy in early-stage triple negative breast cancer
por: Laouris, Panayiotis, et al.
Publicado: (2023)

AC133+ progenitor cells as gene delivery vehicle and cellular probe in subcutaneous tumor models: a preliminary study
por: Rad, Ali M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_1rblqoh4ckpm2pvkb0qbst7kt9